Clinical Trials · NCT02403284
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Phoenix VA Health Care System
- Enrollment
- 97
- Start date
- Mar 2013
- Locations
- 1 site, United States
- Primary endpoint
- Whole Body Insulin Sensitivity (insulin suppression test)